From Lab to Scale in India: What Biotech Startups Must Get Right Before Approaching CDMOs

For many biotech startups, the real risk does not lie in the science — it emerges when promising lab results meet the realities of scale-up, tech transfer, manufacturing, and regulatory execution. This webinar is designed for founders and early teams across biotechnology domains (synthetic biology, agri-biotech, med-tech, industrial biotech, nutraceuticals, and adjacent areas) who are preparing to move beyond proof-of-concept and engage with CROs, CDMOs, or manufacturing partners.

Key takeaways

• Common failure modes during scale-up and tech transfer
• What “manufacturing readiness” really means (beyond lab data and pitch decks)
• How CDMOs evaluate programmes, data packages, and feasibility
• Early validation, compliance, and cost drivers founders often underestimate
• Insights drawn from real-world interactions between startups, CDMOs, regulators, and investors

Who should attend: Biotech innovators and entrepreneurs looking to translate biological innovation into commercial, scalable ventures

Register Now